SCHEMBL20176089

SCHEMBL20176089

CC(C)=CC[Si](C)(C)OC(C)(C#N)CCc1ccccc1

nearest known ligand 0.33

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
TRPV1 Q8NER1 2/20 0.33
DRD2 P14416 1/20 0.32
DRD4 P21917 1/20 0.32
OPRM1 P35372 1/20 0.32
DRD3 P35462 1/20 0.32
PPARG P37231 2/20 0.31
PPARD Q03181 2/20 0.31
PPARA Q07869 2/20 0.31
NDUFS8 O00217 1/20 0.31
COXFA4 O00483 1/20 0.31
NDUFAB1 O14561 1/20 0.31
NDUFA1 O15239 1/20 0.31
NDUFS4 O43181 1/20 0.31
NDUFB5 O43674 1/20 0.31
NDUFB3 O43676 1/20 0.31
NDUFC1 O43677 1/20 0.31
NDUFA2 O43678 1/20 0.31
NDUFS5 O43920 1/20 0.31
NDUFS7 O75251 1/20 0.31
NDUFS2 O75306 1/20 0.31

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL20176087 0.86 DRD2 (0.33) DRD2DRD4OPRM1DRD3
SCHEMBL20176083 0.81 DRD2 (0.35) DRD2DRD4OPRM1DRD3HPGD
SCHEMBL20176092 0.80 DRD2 (0.35) DRD2DRD4OPRM1DRD3CTSS
SCHEMBL20176072 0.80 DRD2 (0.35) DRD2DRD4OPRM1DRD3CTSS
SCHEMBL6724280 0.80 DRD2 (0.38) DRD2DRD4OPRM1DRD3CTSS
SCHEMBL20176086 0.78 DRD2 (0.35) DRD2DRD4OPRM1DRD3ALDH1A1
SCHEMBL20176091 0.77 CTSS (0.33) DRD2DRD4OPRM1DRD3CTSS
SCHEMBL20176093 0.77 EBP (0.33) DRD2DRD4OPRM1DRD3CTSS
SCHEMBL20181078 0.76 ALDH1A1 (0.38) TRPV1PPARAHPGDALDH1A1KDM4E
SCHEMBL20176074 0.76 DRD2 (0.32) DRD2DRD4OPRM1DRD3CTSS

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-10450331-B2 Functionalized cyanosilane and synthesis method and use thereof EAST CHINA NORMAL UNIVERSITY (CN) 2019-10-22 US disclosed
US-20180141964-A1 FUNCTIONALIZED CYANOSILANE AND SYNTHESIS METHOD AND USE THEREOF EAST CHINA NORMAL UNIVERSITY (CN) 2018-05-24 US disclosed
US-20180141964-A1 FUNCTIONALIZED CYANOSILANE AND SYNTHESIS METHOD AND USE THEREOF EAST CHINA NORMAL UNIVERSITY (CN) 2018-05-24 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20180141964-A1 FUNCTIONALIZED CYANOSILANE AND SYNTHESIS METHOD AND USE THEREOF NCLN, PNN, MB TRPV1 4325/4885DRD2 2601/4885DRD4 2341/4885
US-10450331-B2 Functionalized cyanosilane and synthesis method and use thereof NCLN, PNN, MB TRPV1 4325/4885DRD2 2601/4885DRD4 2341/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.